Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2025-12-26 @ 11:13 PM
NCT ID:
NCT00082212
Eligibility Criteria:
Inclusion Criteria:
* subjects must have recurrent or persistent epithelial ovarian or primary peritoneal carcinoma. Histologic confirmation of the original primary tumor is required.
* EGFR expression must be positive as determined by an outside reference lab
* Subjects must have had a treatment-free interval following platinum of \<12 mos
* All subjects must have measurable disease at baseline
* Subjects must have at least one recurrent lesion to be used to assess response
* Recovery from effect of recent surgery, radiotherapy or chemotherapy
Exclusion Criteria:
* Subjects with other invasive malignancies (including peritoneal mesotheliomas)
* Subjects with unstable cardiac disease or MI within 6 mos
* Subjects with Acute hepatitis
* Subjects with active or uncontrolled infection
* A history of prior cetuximab or other therapy which targets the EGFR pathway or prior history of prior chimerized or murine monoclonal antibody therapy
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00082212
Study Brief:
Protocol Section:
NCT00082212